메뉴 건너뛰기




Volumn 12, Issue , 2016, Pages 144-153

Base metal-catalyzed benzylic oxidation of (aryl)(heteroaryl)methanes with molecular oxygen

Author keywords

Base metal; Benzylic; Catalyzed; Molecular oxygen; Oxygenation

Indexed keywords


EID: 84962300761     PISSN: None     EISSN: 18605397     Source Type: Journal    
DOI: 10.3762/bjoc.12.16     Document Type: Article
Times cited : (49)

References (46)
  • 3
    • 84962323665 scopus 로고    scopus 로고
    • European chemicals agency (ECHA) website. http://echa.europa.eu/web/guest/regulations/reach/legislation.
  • 12
    • 80955177193 scopus 로고    scopus 로고
    • Jin, C.; Zhang, L.; Su, W. K. Synlett 2011, 10, 1435-1438. doi:10.1055/s-0030-1260760
    • (2011) Synlett , vol.10 , pp. 1435-1438
    • Jin, C.1    Zhang, L.2    Su, W.K.3
  • 34
    • 0003768904 scopus 로고    scopus 로고
    • VINITI: Moscow-Tartu
    • a values mentioned are those of the corresponding monosubstituted pyridines since the benzyl group is the same in every pyridine and data for the compounds are not available. Tables of Rate and Equilibrium Constants of Heterolytic Organic Reactions; Palm, V., Ed.; VINITI: Moscow-Tartu, 1975-1985.
    • Tables of Rate and Equilibrium Constants of Heterolytic Organic Reactions , pp. 1975-1985
    • Palm, V.1
  • 35
  • 36
    • 0024522746 scopus 로고
    • Adam, S. Tetrahedron 1989, 45, 1409-1414. doi:10.1016/0040-4020(89)80138-3
    • (1989) Tetrahedron , vol.45 , pp. 1409-1414
    • Adam, S.1
  • 37
    • 84962303748 scopus 로고    scopus 로고
    • World Health Organization (WHO) website. http://www.who.int/medicines/publications/essentialmedicines/en/.
  • 43
    • 84962318633 scopus 로고    scopus 로고
    • Class 1 metals include metals that are known or suspect human carcinogens or show any other significant toxicity. Class 2 metals include metals with lower toxicity to man and are typically encountered with administration of medicinal products. Class 3 metals include metals with no significant toxicity and are well tolerated up to doses far exceeding typically encountered with the administration of medicinal products. European medicines agency, committee for medicinal products for human use, see http://www.ema.europa.eu/ema/index.jsp?curNpages/regulation/general/general-content-000356.jsp&mid=WC0b01ac0580028e8c for a detailed description.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.